bpc-157 human clinical trials rcts bpc 157 randomized controlled Sequential biopharmaceutical and regulatory barriers limiting BPC-157 bpc 157 human clinical trial

Can TB500 Help With an Old Injury

10.1016/j.cmi.2019.06.011 59 ElkinsM

The work, which used the protein insulin-like growth factor-1 (IGF-1), showed that an orally delivered, shelf-stable medication grown in lettuce plants could stimulate the growth of bone-building cells and promote bone regeneration

In Phase 2 trials involving 338 participants across all doses, 88.8% of patients at the 12mg dose successfully completed the 48-week study despite experiencing side effects

Its relevance is more focused on recovery biology and tissue repair

However, if you have a significant deficiency, it may take several weeks of regular injections to fully restore your levels and experience maximum benefits